Cited by 56

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid(25–35) induced neurodegeneration in cultured hippocampal neurons

Woods, Alisa G., Cribbs, David H., Whittemore, Edward R., Cotman, Carl W.·1995·Brain Research

Abstract

beta-Amyloid peptide has been reported to be toxic to neurons in vitro and in vivo. The fragment of the beta 1-42 peptide believed to be responsible for this toxicity consists of amino acids 25 to 35. beta-amyloid protein, heparan sulfate (HS) glycosaminoglycan (GAG), and proteoglycan (PG) are all localized throughout the senile plaques found in Alzheimer's disease. Chondroitin sulfate (CS) and dermatan sulfate have also been found at the periphery of senile plaques. We have found that both HS and CS prevented neurite fragmentation and toxicity normally induced by beta 25-35. HS and CS by themselves did not have a significant influence on cell viability, indicating that their protective actions were not due to a general trophic effect. In contrast, cultures treated with HS and beta 1-42 did not show significantly reduced toxicity compared to cultures treated with beta 1-42 alone despite specific binding interactions. These data indicate that one function of GAGs in the brain may be to protect neurons from select toxic insults and injury, and additionally suggest that HS interacts differently with different beta-amyloid fragments. These data further suggest that different beta-amyloid fragments may induce distinct mechanisms of toxicity in vitro.

Overview

Integrity signals

Registry

Crossref · 10.1016/0006-8993(95)00775-l

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 5 references

Research works printed but not linked: 40

  1. Behl, 1994, Hydrogen peroxide mediates amyloid β protein toxicity, Cell, 77, 817, 10.1016/0092-8674(94)90131-7 · DOI · Paper page
  2. Brunden, 1993, pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans, J. Neurochem., 61, 2147, 10.1111/j.1471-4159.1993.tb07453.x · DOI · Paper page
  3. Buee, 1993, Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide, Brain Res., 601, 154, 10.1016/0006-8993(93)91706-X · DOI
  4. Copani, 1991, Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation, Neuroreport, 2, 763, 10.1097/00001756-199112000-00008 · DOI
  5. Cummings, 1993, β-Amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease, Neurobiol. Aging, 14, 547, 10.1016/0197-4580(93)90038-D · DOI
  6. DeWitt, 1993, Chondroitin-sulfate proteoglycans are associated with the lesions of Alzheimer's disease, Exp. Neurol., 121, 149, 10.1006/exnr.1993.1081 · DOI
  7. Fraser, 1992, Effects of sulfate ions on amyloid β/A4 assemblies: implications for amyloid fibril-proteoglycan interactions, J. Neurochem., 59, 1531, 10.1111/j.1471-4159.1992.tb08470.x · DOI
  8. Grant, 1987, Pericellular heparans may contribute to the protection of cells from free radicals, Med. Hypotheses, 23, 67, 10.1016/0306-9877(87)90183-6 · DOI
  9. Hansen, 1989, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill, J. Immunol. Methods, 119, 203, 10.1016/0022-1759(89)90397-9 · DOI
  10. Karlsson, 1988, Binding of human extracellular-superoxide dismutase C to sulphated glycosaminoglycans, Biochem. J., 256, 29, 10.1042/bj2560029 · DOI
  11. Karlsson, 1989, Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells, Lab. Invest., 60, 659
  12. Klagsburn, 1989, The fibroblast growth factor family: structural and biological properties, Prog. Growth Factor Res., 1, 207, 10.1016/0955-2235(89)90012-4 · DOI
  13. Koh, 1990, Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage, Brain Res., 533, 315, 10.1016/0006-8993(90)91355-K · DOI
  14. Kowall, 1992, In vivo neurotoxicity of beta-amyloid [beta(1–40)] and the beta(25–35) fragment, Neurobiol. Aging, 13, 537, 10.1016/0197-4580(92)90053-Z · DOI
  15. Lander, 1982, Characterization of a factor that promotes neurite outgrowth: evidence linking activity to a heparan sulfate proteoglycan, J. Cell Biol., 94, 574, 10.1083/jcb.94.3.574 · DOI
  16. Ledoux, 1992, Interactions of FGFs with target cells, Prog. Growth Factor Res., 4, 107, 10.1016/0955-2235(92)90026-E · DOI
  17. Leveugle, 1994, Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic sulfated compounds, NeuroReport, 5, 1389
  18. Mattson, 1992, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12, 376, 10.1523/JNEUROSCI.12-02-00376.1992 · DOI
  19. Mattson, 1993, Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF, Brain Res., 621, 35, 10.1016/0006-8993(93)90295-X · DOI
  20. Narindrasorasak, 1991, High affinity interactions between the Alzheimer's β-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan, J. Biol. Chem., 20, 12878, 10.1016/S0021-9258(18)98776-4 · DOI
  21. Perlmutter, 1990, Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease, Brain Res., 508, 13, 10.1016/0006-8993(90)91111-S · DOI
  22. Perry, 1991, The association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease, J. Neurosci., 11, 3679, 10.1523/JNEUROSCI.11-11-03679.1991 · DOI
  23. Pike, 1993, Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993 · DOI · Paper page
  24. Pike, 1991, In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res., 563, 311, 10.1016/0006-8993(91)91553-D · DOI
  25. Pollack, 1995, Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells, Neurosci. Lett., 184, 113, 10.1016/0304-3940(94)11182-I · DOI
  26. Schubert, 1987, Multiple influences of a heparin-binding growth factor on neuronal development, J. Cell Biol., 104, 635, 10.1083/jcb.104.3.635 · DOI
  27. Simmons, 1994, Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol., 45, 373
  28. Snow, 1985, Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study, Lab Invest., 53, 37
  29. Snow, 1988, The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease, Am. J. Pathol., 133, 456
  30. Snow, 1989, A characteristic binding affinity between heparan sulfate proteoglycans and the A4 amyloid protein of Alzheimer's disease, J. Neuropathol. Exp. Neurol., 48, 352, 10.1097/00005072-198905000-00160 · DOI
  31. Snow, 1990, Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome, Am. J. Pathol., 137, 1253
  32. Snow, 1987, Sulfated glycosaminoglycans in Alzheimer's disease, Hum. Pathol., 18, 506, 10.1016/S0046-8177(87)80036-9 · DOI
  33. Snow, 1992, Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease, J. Histochem. Cytochem., 40, 105, 10.1177/40.1.1370306 · DOI
  34. Snow, 1987, Sulfated glycoaminoglycans: a common constituent of all amyloids?, Lab Invest., 56, 120
  35. Su, 1992, Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease, Neuroscience, 51, 801, 10.1016/0306-4522(92)90521-3 · DOI
  36. Terry, 1983, Senile dementia of the Alzheimer's type, Ann. Neurol., 14, 497, 10.1002/ana.410140502 · DOI
  37. Walicke, 1988, Interactions between basic fibroblast growth factor (FGF) and glycosaminoglycans in promoting neurite outgrowth, Exp. Neurol., 102, 144, 10.1016/0014-4886(88)90087-8 · DOI
  38. Walicke, 1991, Internalization and processing of basic fibroblast growth factor by neurons and astrocytes, J. Neurosci., 11, 2249, 10.1523/JNEUROSCI.11-07-02249.1991 · DOI
  39. Whittemore, 1994, Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons, Neuroreport, 5, 1485, 10.1097/00001756-199407000-00019 · DOI
  40. Yankner, 1989, Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease, Science, 245, 417, 10.1126/science.2474201 · DOI · Paper page

Cited by

Sorted by citations

See all 56

Metadata

Authors
Woods, A. G., Cribbs, D. H., Whittemore, E. R., & Cotman, C. W.
Venue
Brain Research
Publisher
Elsevier BV
Published
1995-10
Volume
697
Issue
1-2
Pages
53-62
ISSN
0006-8993
Cited by
56
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review